Wednesday, August 19, 2009

Merck & Co. (MRK) Update

I find very interesting the pattern that MRK is developing, as the MRK fundamentals.

From the fundamentals:

Merck & Co. is one of the largest pharmaceutical companies in the world with 2008 annual sales of $24.2 billion. While Merck produces a wide assortment of medications, a few blockbuster drugs bring in the bulk of its revenue. Currently Merck's four most profitable drugs account for more than half of total sales.
The company's decision to acquire rival Schering-Plough (SGP) will be a major expansion, though, as the two companies' combined 2008 revenues were $47 billion.

Some key ratios:

Explore more MRK Data on Wikinvest
Number of drugs in face I:

Explore more MRK Data on Wikinvest


Revenue, Net Income and Net Margin:

Explore more MRK Data on Wikinvest
Interest coverage:

Explore more MRK Data on Wikinvest



You can read more from:

http://www.wikinvest.com/wiki/Mrk

Technical perspective:

MRK Monthly chart:


Daily Chart:




Be careful, tight your stops if you are holding MRK, because it is developing some divergences (RSI, CMF, Accum/Dist, MACD and Force Index).

No comments:

Post a Comment

There was an error in this gadget

Global Markets Heat